Compounds > caffeine

caffeine and adenosine-3',5'-cyclic phosphorothioate

caffeine has been researched along with adenosine-3',5'-cyclic phosphorothioate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Itoh, T; Kanmura, Y; Shiraishi, Y1
Kato, BM; Rubel, EW1
Fahrion, JK; Galas, L; Komuro, H; Komuro, Y; Li, Y; Littner, Y; Ohno, N; Raoult, E; Vaudry, D1

Other Studies

3 other study(ies) available for caffeine and adenosine-3',5'-cyclic phosphorothioate

ArticleYear
Effect of cilostazol, a phosphodiesterase type III inhibitor, on histamine-induced increase in [Ca2+]i and force in middle cerebral artery of the rabbit.
    British journal of pharmacology, 1998, Volume: 123, Issue:5

    Topics: Animals; Caffeine; Calcium; Cerebral Arteries; Cilostazol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Histamine; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Rabbits; Ryanodine; Tetrazoles; Thionucleotides

1998
Glutamate regulates IP3-type and CICR stores in the avian cochlear nucleus.
    Journal of neurophysiology, 1999, Volume: 81, Issue:4

    Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Alanine; Animals; Benzoates; Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Chelating Agents; Chick Embryo; Cochlear Nucleus; Cyclic AMP; Cycloleucine; Cysteine; Egtazic Acid; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Fluorescent Dyes; Fura-2; Gallic Acid; Glutamic Acid; Glycine; Ibotenic Acid; Inositol 1,4,5-Trisphosphate Receptors; Ion Channel Gating; Neurons; Neuroprotective Agents; Neurotransmitter Agents; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Receptors, Cytoplasmic and Nuclear; Ryanodine; Second Messenger Systems; Thionucleotides

1999
Rescue of neuronal migration deficits in a mouse model of fetal Minamata disease by increasing neuronal Ca2+ spike frequency.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, Mar-27, Volume: 109, Issue:13

    Topics: Adenine; Animals; Animals, Newborn; Caffeine; Calcium; Calcium Signaling; Cell Movement; Cerebellum; Cyclic AMP; Disease Models, Animal; Female; Fetal Diseases; Insulin-Like Growth Factor I; Male; Mercury Poisoning, Nervous System; Methylmercury Compounds; Mice; Neurons; Signal Transduction; Thionucleotides

2012